Volume 58, Issue 4, Pages (October 2000)

Slides:

Advertisements

Similar presentations

Kamyar Kalantar-Zadeh Kidney International

Advertisements

Ischemic heart disease after renal transplantation

Volume 60, Issue 1, Pages (July 2001)

Melamine toxicity: one more culprit in calcium kidney lithiasis

E. Cavalier, P. Delanaye, A. Carlisi, J. -M. Krzesinski, J. -P

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Volume 54, Issue 4, Pages (October 1998)

Plasma sodium and hypertension

Propofol-related green urine

Circulating biochemical markers of bone remodeling in uremic patients

Vitamin D deficiency and heart disease

M. Fukagawa, S. Nakanishi, J.J. Kazama Kidney International

Volume 58, Issue 6, Pages (December 2000)

Hiroyuki Kobori, Lisa M. Harrison-Bernard, L. Gabriel Navar

Volume 60, Issue 1, Pages (July 2001)

Kamyar Kalantar-Zadeh Kidney International

Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy? Fu L. Luan, Diane E. Steffick,

Volume 55, Issue 6, Pages (June 1999)

Comorbidity and confounding in end-stage renal disease

The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis Sai Subhodhini Reddy, Jean L. Holley

Volume 74, Issue 3, Pages (August 2008)

Volume 70, Issue 11, Pages (December 2006)

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

Use of vitamin D in chronic kidney disease patients

Volume 87, Issue 2, Pages (February 2015)

Volume 77, Pages S8-S11 (March 2010)

Volume 71, Issue 6, Pages (March 2007)

Prospective randomized study of individual and group psychotherapy versus controls in recipients of renal transplants1 Lyndsay S. Baines, John T. Joseph,

Melamine toxicity: one more culprit in calcium kidney lithiasis

Bone mass evolution after renal transplantation

Volume 87, Issue 1, Pages (January 2015)

Extracorporeal therapy in sepsis: are we there yet?

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Presentation of the 2003 Jean Hamburger Award to Robert W. Schrier

Volume 87, Issue 3, Pages (March 2015)

Volume 85, Issue 1, Pages 3-4 (January 2014)

Volume 56, Issue 4, Pages (October 1999)

The global challenge of chronic kidney disease

Nephrology Crossword: Glomerulonephritis

Volume 78, Issue 4, Pages (August 2010)

A man with a hole in his penis

Volume 87, Issue 5, Pages (May 2015)

Volume 54, Issue 1, Pages (July 1998)

Racial differences in survival of patients on dialysis

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Organ transplantation goes to the movies

Does equal care give equal outcomes?

Stephen P. Mcdonald, Graeme R. Russ Kidney International

Volume 55, Pages S3-S16 (June 1999)

Volume 72, Issue 8, Pages (October 2007)

Volume 63, Issue 6, Pages (June 2003)

Volume 370, Issue 9602, Pages (December 2007)

American Indian heritage and risk factors for renal injury

Volume 69, Issue 10, Pages (May 2006)

Volume 56, Issue 2, Pages (August 1999)

Volume 70, Issue 3, Pages (August 2006)

Stephen G. Rostand, Tilman B. Drüeke Kidney International

Volume 70, Issue 5, Pages (September 2006)

Ischemic heart disease after renal transplantation

The international realities of live donor kidney transplantation

Volume 55, Issue 3, Pages (March 1999)

Evaluation of the Losartan in Hemodialysis (ELHE) Study

Abby S. Kazley, Kit N. Simpson, Kenneth D. Chavin, Prabhakar Baliga

Volume 74, Issue 10, Pages (November 2008)

Volume 57, Issue 2, Pages (October 2000)

Global trends in the rates of living kidney donation

Marta Christov, Harald Jüppner Kidney International

Ronen Levi, Justin Silver Kidney International

Volume 62, Issue 5, Pages (November 2002)

Presentation transcript:

Volume 58, Issue 4, Pages 1788-1796 (October 2000) Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation François Pierre Westeel, Hakim Mazouz, Fatima Ezaitouni, Carine Hottelart, Christina Ivan, Patrice Fardellone, Michel Brazier, Isabelle El Esper, Jacques Petit, Jean Michel Achard, André Pruna, Albert Fournier Kidney International Volume 58, Issue 4, Pages 1788-1796 (October 2000) DOI: 10.1046/j.1523-1755.2000.00341.x Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 1 Follow-up of bone remodeling markers (BRMs) (A) and treatment (B). Symbols are: (▪) parathyroid hormone; (□) osteocalcin; (▴) total alkaline phosphatase; (▵) bone alkaline phosphatase; (○) pyridinoline; (•) Deoxypyridinoline. Black boxes represent steroid doses. Kidney International 2000 58, 1788-1796DOI: (10.1046/j.1523-1755.2000.00341.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 2 Correlation of plasma osteocalcin increase at six months and mean trough level of cyclosporine during the first six months (P = 0.01; r = 0.48; N = 28). Kidney International 2000 58, 1788-1796DOI: (10.1046/j.1523-1755.2000.00341.x) Copyright © 2000 International Society of Nephrology Terms and Conditions